Alcidion GroupASX:ALC +1.05% EV-to-FCF is 16.14 as of Jun. 27, 2026. The stock has 4 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Alcidion Group ranks better than 52.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alcidion Group's Enterprise Value is A$115.79 Mil.
Alcidion Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$7.18 Mil. Therefore, Alcidion Group's EV-to-FCF for today is 16.14.
The historical rank and industry rank for Alcidion Group's EV-to-FCF or its related term are showing as below:
ASX:ALC'
s EV-to-FCF Range Over the Past 10 Years
Min: -512.36 Med: -9.77 Max: 296.68
Current: 16.51
During the past 13 years, the highest EV-to-FCF of Alcidion Group was 296.68. The lowest was -512.36. And the median was -9.77.
ASX:ALC's EV-to-FCF is ranked better than 52.44% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs ASX:ALC: 16.51
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alcidion Group's PE Ratio (TTM) for today is calculated as:
Alcidion Group's share price for today is A$0.096.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alcidion Group EV-to-FCF Related Terms
Alcidion Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Alcidion Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Alcidion Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Alcidion Group's EV-to-FCF falls into.
Alcidion Group's current Enterprise Value is A$115.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$7.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a EV-to-FCF of 16.14 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #195 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 47.6%.
Is Alcidion Group's EV-to-FCF too high?
Alcidion Group's current EV-to-FCF is 16.14. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. Alcidion Group's value of 16.14 is 7.4% below this industry median. Based on the distribution chart, Alcidion Group ranks #195 out of 410 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Alcidion Group's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #195 out of 410 companies for EV-to-FCF. This puts Alcidion Group in the upper half of its industry. The industry median EV-to-FCF is 17.44. Alcidion Group's value of 16.14 is 7.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current EV-to-FCF of 16.14 is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current EV-to-FCF is 16.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 20% below its estimated fair value. The current EV-to-FCF is 16.14 and 7.4% below the Healthcare Providers & Services industry median of 17.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current EV-to-FCF is 16.14 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 